ImmuCell Corporation Deferred Foreign Income Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Deferred Foreign Income Tax Expense (Benefit) of $296.35 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2020-03-27
- ImmuCell Corporation deferred foreign income tax expense (benefit) for fiscal 2019 was $296.35K, a 76.12% decline from fiscal 2018.
- ImmuCell Corporation deferred foreign income tax expense (benefit) for fiscal 2018 was $1.24M.
- ImmuCell Corporation deferred foreign income tax expense (benefit) for fiscal 2012 was $0.00.
- ImmuCell Corporation deferred foreign income tax expense (benefit) for fiscal 2011 was $0.00.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2019-12-31 | $296.35K 10-K · filed 2020-03-27 |
| 2018-12-31 | $1.24M 10-K · filed 2020-03-27 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-28 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-28 |
| 2010-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |